AxoSim’s new 3D Mini-Brain technology enables human-relevant oligodendrocyte myelination, representing a breakthrough for testing in neurotoxicity and neurodegenerative diseases. This proprietary platform was invented in 2016 by Dr. Thomas Hartung at Johns Hopkins and has been exclusively licensed by AxoSim. Our Mini-Brains recreate a truly biomimetic 3D environment, featuring a unique combination of neurons, astrocytes, and oligodendrocytes.

We deliver human data, faster.